Cargando…
COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
Autores principales: | Estirado, Alicia Domínguez, Ibarra, Gabriela Zambrano, Skrabski, Filip, De Castro Martínez, Francisco Javier, De Pedro, Julia, Sanz Sanz, Maria Pilar, Zubeldia, Jose, Rodriguez, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849526/ http://dx.doi.org/10.1016/j.jaci.2020.12.177 |
Ejemplares similares
-
Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015
por: Ibarra-Meneses, Ana Victoria, et al.
Publicado: (2019) -
Third wave of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021) -
Effectiveness and Safety of Bronchial Thermoplasty in Severe Asthma in Clinical Practice in Spain
por: Puente-Maestu, Luis, et al.
Publicado: (2018) -
Enterovirus A71 Infection and Neurologic Disease, Madrid, Spain, 2016
por: Taravilla, Carmen Niño, et al.
Publicado: (2019) -
Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
por: Hernandez-Aguado, Juan J., et al.
Publicado: (2022)